Felix joined Forbion at the Naarden office in 2024 and is currently an Analyst in the BioEconomy team
Prior to Forbion, Felix co-founded Nucleate in Germany as part of the global non-profit organisation Nucleate, which is building the world’s largest community and educational organisation facilitating the formation of pioneering biotech companies. Felix has gained profound start-up experience, namely from his engagement with two early-stage stage start-ups in the advanced materials and biotech tools space in Singapore and Munich, and from building the start-up accelerator program in Germany with Nucleate.
Felix has a background in molecular biotechnology and finance built throughout his BSc. and MSc. studies at Technical University of Munich (TUM), National University of Singapore, and Technical University of Denmark.
